PRECLINICAL RATIONAL, SAFETY, AND PRELIMINARY EFFICACY RESULTS OF WEEKLY EVEROLIMUS, CARBOPLATIN AND PACLITAXEL AS AN INDUCTION THERAPY FOR PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED HEAD & NECK SQUAMOUS CELL CARCINOMA (CAPRA): A GERCOR-IRC PHASE I/II STUDY

被引：0
|
作者：
Faivre, S. [1 ]
Dreyer, C. [1 ]
Raymond, E. [1 ]
Fayette, J. [2 ]
Delord, J. P. [3 ]
Gatineau, M. [4 ]
Chibaudel, B. [5 ]
Aissat, N. [5 ]
Slimane, K. [6 ]
Le Tourneau, C. [7 ]
机构：
[1] Beaujon Univ Hosp, Oncol Dept, Clichy, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Ctr Claudius Regaud, Clin Res Unit, Toulouse, France
[4] Hop St Joseph, F-75674 Paris, France
[5] GERCOR IRC, Paris, France
[6] Novartis Pharmaceut, Oncol, Rueil Malmaison, France
[7] Inst Curie, Clin Trial Unit, Dept Med Oncol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：334 / 334
页数：1
相关论文
共 50 条
  • [21] A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN)
    Karapanagiotou, E. M.
    Chester, J. D.
    Pandha, H. S.
    Gill, G. M.
    Coffey, M. C.
    Mettinger, K.
    Harrington, K. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Paclitaxel and carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. A phase II study.
    Hiller, S
    Mergenthaler, HG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 507S - 507S
  • [23] PHASE I/II STUDY OF ERLOTINIB COMBINED WITH CISPLATIN AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Herchenhorn, Daniel
    Dias, Fernando L.
    Viegas, Celia M. P.
    Federico, Miriam H.
    Araujo, Carlos Manoel M.
    Small, Isabelle
    Bezerra, Marcos
    Fontao, Karina
    Knust, Renata E.
    Ferreira, Carlos G.
    Martins, Renato G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 696 - 702
  • [24] Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort
    Segal, Neil H.
    Ou, Sai-Hong, I
    Balmanoukian, Ani
    Fury, Matthew G.
    Massarelli, Etiuinia
    Brahmer, Julie R.
    Weiss, Jared
    Schoffski, Patrick
    Antonia, Scott J.
    Massard, Christophe
    Zandberg, Dan P.
    Khleif, Samir N.
    Xiao, Feng
    Rebelatto, Marlon C.
    Steele, Keith E.
    Robbins, Paul B.
    Angra, Natasha
    Song, Xuyang
    Abdullah, Shaad
    Butler, Marcus
    EUROPEAN JOURNAL OF CANCER, 2019, 109 : 154 - 161
  • [25] Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma
    Haddad, R. I.
    Massarelli, E.
    Lee, J. J.
    Lin, H. Y.
    Hutcheson, K.
    Lewis, J.
    Garden, A. S.
    Blumenschein, G. R.
    William, W. N.
    Pharaon, R. R.
    Tishler, R. B.
    Glisson, B. S.
    Pickering, C.
    Gold, K. A.
    Johnson, F. M.
    Rabinowits, G.
    Ginsberg, L. E.
    Williams, M. D.
    Myers, J.
    Kies, M. S.
    Papadimitrakopoulou, V.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 471 - 477
  • [26] Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck
    Schwartz, DL
    Montgomery, RB
    Yueh, B
    Donahue, M
    Anzai, Y
    Canby, R
    Buelna, R
    Anderson, L
    Boyd, C
    Hutson, J
    Keegan, K
    CANCER, 2005, 103 (12) : 2534 - 2543
  • [27] A Phase I/II Study of Concurrent Abraxane, Carboplatin and IMRT for Locally Advanced Squamous Cell Cancer of the Head and Neck (LASCCHN)
    Tishler, R. B.
    Lorch, J.
    Sher, D.
    Clark, J.
    Chan, A.
    Suda, M.
    Balboni, T.
    Busse, P.
    Haddad, R.
    Wirth, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S494 - S494
  • [28] Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck
    Planting, AST
    deMulder, PHM
    deGraeff, A
    Verweij, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (01) : 61 - 65
  • [29] A phase I/II study of oncolytic reovirus plus chemotherapy (carboplatin/paclitaxel) in patients with advanced solid tumors (with emphasis on patients with squamous cell carcinoma of the head and neck (SCCHN)
    Harrington, Kevin J.
    Karapanagiotou, Eleni M.
    Hardev, Pandha
    Nutting, Christopher M.
    Gore, Martin
    Karl, Mettinger
    Geoff, Hall
    Melcher, Alan
    Mercel, Ball
    Coffey, Matt
    Thompson, Brad
    Chester, John
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [30] Long term followup of a phase I study of concurrent paclitaxel and radiation for locally advanced squamous cell carcinoma of the head and neck
    Mansueti, J.
    Likhacheva, A.
    Albert, P.
    Scuito, L.
    Harold, N.
    Rudy, S.
    Colevas, D.
    Morris, J. C.
    Van Waes, C.
    Citrin, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S444 - S444
12345